Patents by Inventor Zita Csákai

Zita Csákai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080058323
    Abstract: The subject invention relates to carboxamidine derivatives, to pharmaceutical compositions containing the carboxamidine derivatives of the invention, and the use thereof for the treatment of vascular diseases and in the preparation of pharmaceutical compositions for the treatment of vascular diseases.
    Type: Application
    Filed: October 30, 2007
    Publication date: March 6, 2008
    Inventors: Zita Csakai, Ede Marvanyos, Laszlo Urogdi, Magdolna Torok, Laszlo Denes
  • Publication number: 20060058294
    Abstract: The invention relates to carboxamidine derivatives to pharmaceutical compositions containing the same and the use thereof in the preparation of pharmaceutical compositions for the treatment of vascular diseases.
    Type: Application
    Filed: January 10, 2003
    Publication date: March 16, 2006
    Inventors: Zita Csakai, Ede Marvanyos, Laszlo Urogdi, Magdolna Torok, Laszlo Denes
  • Publication number: 20050043295
    Abstract: The subject invention relates to carboxamidine derivatives, to pharmaceutical compositions containing the carboxamidine derivatives of the invention, and the use thereof for the treatment of vascular diseases and in the preparation of pharmaceutical compositions for the treatment of vascular diseases.
    Type: Application
    Filed: July 12, 2004
    Publication date: February 24, 2005
    Inventors: Zita Csakai, Ede Marvanyos, Laszlo Urogdi, Magdolna Torok, Laszlo Denes
  • Patent number: 6649628
    Abstract: N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: November 18, 2003
    Assignee: Biorex Kutato es Fejleszto RT
    Inventors: Maria Kürthy, Katalin Bíró, Károly Nagy, László Ürögdi, Zita Csákai, Jenö Szilbereky, Tamás Mogyorósi, Magdolna Török, András Komáromi, Ede Márványos, Mihály Barabás, Mihályné Kardos, Zoltán Nagy, László Korányi, Melinda Nagy
  • Patent number: 6384029
    Abstract: The invention relates to (−)-5,6-dihydro-5-(1-piperidinyl)-methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine to the therapeutical use thereof and to phamaceutical compositions containing the compounds as active ingredient.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: May 7, 2002
    Assignee: Biorex Kutató Fejlesztö RT.
    Inventors: Andrea Jednákovits, Lászió Ürögdi, Lászió Dénes, István Kurucz, Ede Márványos, Mihály Barabás, Ernö Bácsy, Zsuzsanna Korom, Zoltán Nagy, László Ürge, Jenö Szilbereky, Károly Acsai, Péter Krajcsi, Zita Csákai, Magdolna Török
  • Publication number: 20010051630
    Abstract: This invention relates to the use of hydroxylamine derivatives of general formula (I), wherein R1 represents phenyl, N-heteroaryl, S-heteroaryl or a naphthyl group any of which may be unsubstituted or substituted, an unsubstituted or substituted phenylamino or alkylamino or lower alkoxy; X represents halo, amino or an unsubstituted or substituted phenylamino group, or amino substituted with one or two lower alkyl or a hydroxy group, provided that if R1 represents unsubstituted or substituted phenylamino, alkylamino or lower alkoxy, then X is not halo; Y represents hydrogen, hydroxy or alkanoyloxy, with the proviso that simultaneously R1 may not represent phenyl, halophenyl, alkoxyphenyl, N-heteroaryl or naphthyl, X may not represent halo, hydroxy or amino and Y may not represent hydrogen or hydroxy; R2 and R3, independently from each other, represent hydrogen or lower alkyl group, provided that R2 and R3 are not hydrogen simultaneously, or R2 and R3 along with the adjacent nitrogen atom form a 5- to 7-membere
    Type: Application
    Filed: January 10, 2001
    Publication date: December 13, 2001
    Inventors: Andrea Jednakovits, Gabor Galiba, Laszlo Urogdi, Jeno Szilbereky, Ede Marvanyos, Gabor Kocsy, Laszlo Stehly, Tamas Berzy, Mihaly Barabas, Zita Csakai, Magdolna Torok